Form 4 for HCAT Health Catalyst, Inc.
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001562180-23-002428 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-03 | 2023-03-01 | HCAT | Alger Jason | CAO | A - Grant | $0.00 | +1,142 | 58.3K | +2% | $0 | |
| 2023-03-03 | 2023-03-01 | HCAT | Alger Jason | CAO | F - Tax | $14.29 | -1,614 | 57.1K | -3% | -$23.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | A | A | 1,142 | $0.00 | 58,290 | D | — | — | (F2) Represents an award of 1,142 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2022, the PRSUs noted above vested on March 1, 2023. |
| 2 | Common | Common Stock | 2023-03-01 | F | D | 1,614 | $14.29 | 57,148 | D | — | — |